This precaution aims to minimize the risk of aspiration and related complications
Pasternak B, Wintzell V, Eliasson B, et al
Targeting a Major Emerging Need in the GLP-1 Market The Company believes the rapid adoption of GLP-1 and related incretin-based obesity treatments, such as semaglutide and tirzepatide, may create an emerging opportunity for complementary approaches focused on preserving lean muscle mass during weight loss
Retatrutide 12 mg is not designated for medical, diagnostic, or therapeutic applications
In this context, GLP-1RAs can inhibit the secretion of IL-2 and interferon (IFN)-, thereby regulating the immune microenvironment and preventing diabetes [144]
Both hormones influence insulin and glucagon secretion, but GLP-1 has stronger effects on weight loss and heart health